LANTIDRA (Donislecel) Emerging Drug Insights and Market Forecasts, 2019-2032: A Novel Cellular Therapy Being Evaluated for Use in Brittle Type 1 Diabetes
January 24, 2024 07:51 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LANTIDRA Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "LANTIDRA Emerging Drug...
GLIOVAC (ERC1671) Emerging Drug Insight and Market Forecasts, 2032: Comprehensive Analysis of the Future of Glioblastoma Multiforme Treatment in Major Markets
January 24, 2024 07:50 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "GLIOVAC Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report meticulously...
Myotonic Dystrophy Market Forecast: Comprehensive Study on NAMUSCLA (Mexiletine) - Forecasts to 2032
January 24, 2024 07:49 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "NAMUSCLA Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The latest research...
Berubicin Emerging Drug Insights and Market Forecasts, 2019-2032: An Anthracycline, A Class of Anticancer Agents that are Among the Most Powerful Chemotherapy Drugs
January 24, 2024 07:48 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Berubicin Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
Healthcare Industry Report: DB102 Emerging Drug Insights and Market Forecast for DLBCL through 2032
January 24, 2024 07:47 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DB102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. A newly compiled research report...
Plamotamab (Previously XmAb13676) Emerging Drug Insight and Market Forecasts, 2032: A Tumor-targeted Antibody that Contains Both a CD20 Binding Domain and a Cytotoxic T-cell Binding Domain (CD3)
January 24, 2024 07:46 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Plamotamab Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
United States PENTHROX (Methoxyflurane) Emerging Drug Insight and Market Forecasts 2019-2023 and 2023-2032
January 24, 2024 07:45 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "United States PENTHROX Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This...
WEGOVY (Semaglutide): An Analog of the Human Glucagon-like Peptide-1 (GLP-1) Hormone - Emerging Drug Insight and Market Forecasts to 2032
January 24, 2024 07:44 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "WEGOVY Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed...
Global Drug Discovery Informatics Market Report 2023-2030 - Key Industry Participants Focus on Strategic Acquisitions to Sustain the Market Competition
January 24, 2024 05:31 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Workflow (Discovery Informatics, Biocontent Management), Services...
Peripheral Neuropathy Market Size Worth USD 8.54 Billion in 2032 | Emergen Research
January 22, 2024 10:57 ET
|
Emergen Research
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global peripheral neuropathy market size was USD 3.61 Billion in 2022 and is expected to register a revenue CAGR of 9.0% during the forecast period....